These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2886980)

  • 21. Expression of the ets-1 proto-oncogene in human thyroid tumor.
    Nakayama T; Ito M; Ohtsuru A; Naito S; Nakashima M; Sekine I
    Mod Pathol; 1999 Jan; 12(1):61-8. PubMed ID: 9950164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A frequent HindIII RFLP on chromosome 3p21-25 detected by a genomic erbA beta sequence.
    Gareau JL; Houle B; Leduc F; Bradley WE; Dobrovic A
    Nucleic Acids Res; 1988 Feb; 16(3):1223. PubMed ID: 2894009
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression of human and viral ets genes in E. coli production of human ets-2-specific monoclonal antibodies.
    Seth A; Watson DK; Fujiwara S; Showalter SD; Papas TS
    Oncogene Res; 1989; 5(1):61-6. PubMed ID: 2674859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of ets1 proto-oncogene for breast cancer progression.
    Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H
    Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ets up-regulates MET transcription.
    Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
    Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
    Hagman J; Grosschedl R
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of protooncogenes during lymphocyte activation by growth factors.
    Bulanova EG; Budagyan VM; Yarilin AA; Mazurenko NN
    Biochemistry (Mosc); 1997 Sep; 62(9):1021-5. PubMed ID: 9457764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yeast artificial chromosome cloning of 3.2 megabases within chromosomal band 11q24 closely linking c-ets 1 and Fli-1 and encompassing the Ewing sarcoma breakpoint.
    Selleri L; Giovannini M; Hermanson GG; Romo A; Quackenbush J; Penny L; Khristich JV; Evans GA
    Genomics; 1994 Jul; 22(1):137-47. PubMed ID: 7959760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A polymorphic SstI site within the human ets-1 gene in the 11q23 region.
    Sacchi N; Perroni L; Papas TS
    Nucleic Acids Res; 1986 Dec; 14(23):9545. PubMed ID: 2879272
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of the ets-1 proto-oncogene in human breast carcinoma: differential expression with histological grading and growth pattern.
    Katayama S; Nakayama T; Ito M; Naito S; Sekine I
    Histol Histopathol; 2005 Jan; 20(1):119-26. PubMed ID: 15578430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proto-oncogene Ets-1 and the kidney.
    Razzaque MS; Naito T; Taguchi T
    Nephron; 2001 Sep; 89(1):1-4. PubMed ID: 11528223
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1.
    McNagny KM; Sieweke MH; Döderlein G; Graf T; Nerlov C
    EMBO J; 1998 Jul; 17(13):3669-80. PubMed ID: 9649437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphatics and vascular channels; the differences behind similarity.
    Jones PF
    J Pathol; 2003 Aug; 200(5):551-2. PubMed ID: 12898589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.
    Ito T; Nakayama T; Ito M; Naito S; Kanematsu T; Sekine I
    Mod Pathol; 1998 Feb; 11(2):209-15. PubMed ID: 9504693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene.
    Bories JC; Willerford DM; Grévin D; Davidson L; Camus A; Martin P; Stéhelin D; Alt FW
    Nature; 1995 Oct; 377(6550):635-8. PubMed ID: 7566176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. StuI RFLP in the human ABL locus.
    Baumann R; Smith M
    Nucleic Acids Res; 1990 Feb; 18(3):693. PubMed ID: 1968633
    [No Abstract]   [Full Text] [Related]  

  • 38. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
    Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription.
    Rutter JL; Mitchell TI; Butticè G; Meyers J; Gusella JF; Ozelius LJ; Brinckerhoff CE
    Cancer Res; 1998 Dec; 58(23):5321-5. PubMed ID: 9850057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.
    Ozaki I; Mizuta T; Zhao G; Yotsumoto H; Hara T; Kajihara S; Hisatomi A; Sakai T; Yamamoto K
    Cancer Res; 2000 Nov; 60(22):6519-25. PubMed ID: 11103822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.